Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Histology and Histopathology
|
July 25, 2007
Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation
Y-L Choi, J Kim, M J Kwon, et al.
Oncogene
|
August 16, 2006
A genomic analysis of adult T-cell leukemia
Y L Choi, K Tsukasaki, M C O'Neill, et al.
British Journal of Cancer
|
February 2, 2012
Clinical significance of CD151 overexpression in subtypes of invasive breast cancer
M J Kwon, S Park, J Y Choi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2015
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer
S H Lim, M Hong, S Ahn, et al.
Histology and Histopathology
|
August 27, 2011
Detection of Merkel cell polyomavirus in Merkel cell carcinomas and small cell carcinomas by PCR and immunohistochemistry
H S Jung, Y-L Choi, J-S Choi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2016
Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial
S-H Lee, J-K Lee, M-J Ahn, et al.
Nature Communications
|
July 14, 2025
Author Correction: Elevated heterotrophic activity in Guaymas Basin hydrothermal plumes influences deep-sea carbon cycling
Andrew Montgomery, Guang-Chao Zhuang, Zhichao Zhou, et al.
Nature Communications
|
May 28, 2025
Elevated heterotrophic activity in Guaymas Basin hydrothermal plumes influences deep-sea carbon cycling
Andrew Montgomery, Guang-Chao Zhuang, Zhichao Zhou, et al.
ESMO Open
|
February 14, 2022
Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study
S Park, J-M Sun, Y-L Choi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2020
HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients
J H Shim, H S Kim, H Cha, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Histology and Histopathology
|
July 25, 2007
Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation
Y-L Choi, J Kim, M J Kwon, et al.
Oncogene
|
August 16, 2006
A genomic analysis of adult T-cell leukemia
Y L Choi, K Tsukasaki, M C O'Neill, et al.
British Journal of Cancer
|
February 2, 2012
Clinical significance of CD151 overexpression in subtypes of invasive breast cancer
M J Kwon, S Park, J Y Choi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2015
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer
S H Lim, M Hong, S Ahn, et al.
Histology and Histopathology
|
August 27, 2011
Detection of Merkel cell polyomavirus in Merkel cell carcinomas and small cell carcinomas by PCR and immunohistochemistry
H S Jung, Y-L Choi, J-S Choi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2016
Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial
S-H Lee, J-K Lee, M-J Ahn, et al.
Nature Communications
|
July 14, 2025
Author Correction: Elevated heterotrophic activity in Guaymas Basin hydrothermal plumes influences deep-sea carbon cycling
Andrew Montgomery, Guang-Chao Zhuang, Zhichao Zhou, et al.
Nature Communications
|
May 28, 2025
Elevated heterotrophic activity in Guaymas Basin hydrothermal plumes influences deep-sea carbon cycling
Andrew Montgomery, Guang-Chao Zhuang, Zhichao Zhou, et al.
ESMO Open
|
February 14, 2022
Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study
S Park, J-M Sun, Y-L Choi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2020
HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients
J H Shim, H S Kim, H Cha, et al.
Page
of 6